Dynamic Proteomic Profiling in a 5-week Crossover Trial of Liraglutide in Obesity Reveals Weight-Dependent Myostatin Downregulation and Multi-Pathway Effects Beyond Weight Reduction
Related Media
Are you sure you want to reset your password?
If so, you will be redirected to the Authentication Service
